Remove 2009 Remove COVID-19 Remove Governance Remove Public Health
article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

Bill of Health

Last month, the patent battle between COVID-19 mRNA vaccine manufacturers continued with BioNTech/Pfizer filing a strong defense and counter-claim to Moderna’s allegations of patent infringement. Indeed, as made public, the U.S. Moderna has since made over $30 billion in COVID-19 vaccine sales. By Aparajita Lath.

article thumbnail

Using Legal Preparedness to Minimize Liability Barriers to Accessing Pandemic Vaccine and Medical Countermeasures

Bill of Health

In a public health emergency, pharmaceutical manufacturers’ liability concerns can slow the deployment of urgently needed vaccines and other medical countermeasures (MCMs). Products used during public health emergencies raise unique issues either because of their novelty, scale and type of proposed use, or regulatory pathway.

COVID-19 201
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biosafety Labs, Public Safety, and Politics

Bill of Health

By Barbara Pfeffer Billauer On May 25, 2023 , merely six weeks before the Wuhan Biosafety lab lost its NIH funding amid the controversy of possible lab leaks and connection with COVID-19, the United States proudly opened the doors of the National Bio and Agro-Defense Facility (NBAF), the 14th biosafety level 4 lab in the U.S.,

article thumbnail

American Hospital Association Urges DEA to Issue Special Registration for Telemedicine Controlled Substances

Healthcare Law Today

The American Hospital Association (AHA), on behalf of its nearly 5,000 member hospitals and health systems, sent a letter urging the Drug Enforcement Agency (DEA) to take immediate action to allow telemedicine prescribing of controlled substances before the Public Health Emergency (PHE) waivers expire.

article thumbnail

Trust Is a Key Social Currency for COVID-Embattled Consumers

Health Populi

Combine these new life-flows with conflicting information about the nature, severity, and life-span of COVID-19: From three levels of government leaders: The President and the Executive Branch at the Federal Level, Governors of States, and Mayors of cities; Public health agencies, especially the U.S.

article thumbnail

What John Mackey of Whole Foods Said at the 2022 HIMSS Conference – and Why This is Important for the Whole Health Ecosystem

Jane Sarashon

Health Populi’s Hot Points: John Mackey has held this view on food for a long time. Mackey told NPR in this interview that, “In fascism, the government doesn’t own the means of production, but they do control it. Yes, to health care access (especially primary care). Yes, to healthy food.

article thumbnail

DOJ Recouped $2.2 Billion Under FCA in 2022

Hall Render

Whistleblowers continue to be one of the federal government’s greatest assets in FCA cases, as whistleblowers filed 652 qui tam suits in 2022 with recovery totaling $1.9 The government initiated 296 FCA cases on its own last year without input of a relator, which is the highest volume of DOJ initiated cases since the 1986 FCA amendments.